AimsSecondary tricuspid regurgitation (TR) is associated with poor prognosis in acute decompensated heart failure (ADHF). However, its dynamic evolution in response to volume status and treatment has never been previously investigated. In this study, we sought to explore the in-hospital evolution of TR in ADHF patients and to assess its prognostic implications.Methods and resultsWe retrospectively enrolled patients admitted for ADHF with >= 2 in-hospital echocardiographic evaluations of TR. Patients were categorized, according to TR evolution, into persistent moderate-severe TR, improved TR (from moderate-severe to trivial-mild) and persistent trivial-mild TR. The primary endpoint was a composite of 5-year all-cause mortality and heart failure hospitalization (HFH). A total of 1054 patients were included. Of 318 patients (30%) with moderate-severe TR at admission, 49% improved TR severity and showed better trends of decongestion, whereas those who maintained persistent moderate-severe TR had characteristics of more severe heart failure at admission and discharge. Atrial fibrillation, previous heart failure and higher dosage of loop diuretics before admission were associated with a lower probability of improved TR. After adjustment, improved TR was associated with lower risk of 5-year all-cause mortality/HFH compared with persistent moderate-severe TR (hazard ratio [HR] 0.524, p = 0.008) and no different from persistent trivial-mild TR (HR 0.878, p = 0.575). Results were consistent across all subgroups of in-hospital variation of mitral regurgitation.ConclusionAmong ADHF patients with moderate-severe TR at admission, 49% had an in-hospital improvement in TR severity, which was associated with a reduction in risk of 5-year all-cause mortality and morbidity outcomes. Dynamic evolution of tricuspid regurgitation (TR) in patients hospital for acute decompensated heart failure (ADHF) and its association with long-term outcomes. HF, heart failure. image
机构:
Nihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, Japan
Mizobuchi, Saki
Saito, Yuki
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, Japan
Saito, Yuki
论文数: 引用数:
h-index:
机构:
Fujito, Hidesato
Miyagawa, Masatsugu
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, Japan
Miyagawa, Masatsugu
Kitano, Daisuke
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, Japan
Kitano, Daisuke
Toyama, Kazuto
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, Japan
Toyama, Kazuto
Fukamachi, Daisuke
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, Japan
Fukamachi, Daisuke
Okumura, Yasuo
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Dept Med, Div Cardiol, 30-1 Ohyaguchi Kamicho,Itabashi ku, Tokyo 1738610, Japan